Drug Trial Radar · NCT02223949
Labor Induction and Maternal BMI, Comparison of Different Pre-induction Cervical Ripening Methods
Last checked: Nov 19, 2026Latest source record: Aug 22, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
624
Planned (sponsor's estimate)
Start
Oct 2014
Primary completion
Oct 2016
Study completion Nov 2016
Sponsor
- Lead sponsor
- Hillel Yaffe Medical CenterGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- First posted
- Aug 22, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years, up to 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate whether mechanical cervical ripening (using the Cook double balloon catheter) is superior or inferior to pharmacological agents (PGE1) in overweight and obese women undergoing labor induction.
Conditions
- Obesity
- Labor Complications
Interventions
Cook double balloon catheterDevice
PGE1 tabletDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cesarian section rateTime frame: 24 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hillel Yaffe Medical Center
Hadera, Israel
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.